Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

By C. Lai, R. Beasley, Julian Crane, S. Foliaki, J. Shah, S. Weiland. Thorax, 2009

1,045 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma (2012, neutral): “INTRODUCTION Allergic asthma affects over 100 million people worldwide and its prevalence is increasing, particularly among children in industrialized countries [1].”
The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. (2013, background): “The majority of the new ISAAC centres were from countries in Latin America, Eastern Europe and Africa, although there were also some from other regions.(7) In the case of rhinoconjunctivitis, the 13--14-year age group involved 670,242 children and 388,811 children aged 6--7 years.”
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. (2009, background): “Only the eczema data are reported and discussed here; the asthma and rhinoconjunctivitis results are reported separately.(15,16) Questionnaires were translated, if necessary, from English into the local language for both age groups.”